Keith D Dawkins

SVP and Chief Medical Officer

Boston Scientific Corporation, Natick, MA, US

Articles by Keith D Dawkins, SVP and Chief Medical Officer

Platinum Chromium Stent Series – The TAXUS™ Element™ (ION™), PROMUS Element™ and OMEGA™ Stents

Dominic J Allocco, Mary V Jacoski, Barbara Huibregtse, et al

Citation: Interventional Cardiology 2011;6(2):134–41

DOI:

https://doi.org/10.15420/icr.2011.6.2.134
Differential Drug-eluting Stent Effects in Patients with Diabetes - Bench-to-bedside Evidence for Neointimal Suppression and Restenosis Reduction

Adrian P Banning, Kristin L Hood, Aloke V Finn, et al

Citation: Interventional Cardiology 2010;5:27–34

DOI:

https://doi.org/10.15420/icr.2010.5.1.27